Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

An E2F dominant negative mutant blocks E1A induced cell cycle progression

S F Dobrowolski1, D W Stacey, M L Harter

  • 1Department of Molecular Biology, Cleveland Clinic Foundation, Ohio 44195-5178.

Oncogene
|September 1, 1994
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The assembly competence domain is essential for inv(16)-associated acute myeloid leukemia.

Leukemia·2017
Same author

Myeloid translocation genes differentially regulate colorectal cancer programs.

Oncogene·2016
Same author

DNA methylation in the pathophysiology of hyperphenylalaninemia in the PAH(enu2) mouse model of phenylketonuria.

Molecular genetics and metabolism·2016
Same author

Methylome repatterning in a mouse model of Maternal PKU Syndrome.

Molecular genetics and metabolism·2014
Same author

Biochemical characterization of mutant phenylalanine hydroxylase enzymes and correlation with clinical presentation in hyperphenylalaninaemic patients.

Journal of inherited metabolic disease·2008
Same author

Histone deacetylase inhibitors induce the degradation of the t(8;21) fusion oncoprotein.

Oncogene·2006
Same journal

Correction: Neuropilin-1 promotes human glioma progression through potentiating the activity of the HGF/SF autocrine pathway.

Oncogene·2026
Same journal

Amphiregulin-mediated EGFR activation drives both intrinsic and acquired resistance to KRAS G12C inhibitors in KRAS G12C-mutant non-small cell lung cancer.

Oncogene·2026
Same journal

Histone lactylation-driven IGF2BP3 promotes intrahepatic cholangiocarcinoma progression via SPP1/CD44-dependent macrophage polarization.

Oncogene·2026
Same journal

Correction: SIRT7 activates p53 by enhancing PCAF-mediated MDM2 degradation to arrest the cell cycle.

Oncogene·2026
Same journal

Correction: Liver-specific SIRT1 knockout-induced hyperglycemia promotes spontaneous lung adenocarcinomas through HSF1-MDM2.

Oncogene·2026
Same journal

Correction: 6-Phosphofructo-2-kinase/fructose-2,6-biphosphatase 4 is essential for p53-null cancer cells.

Oncogene·2026
See all related articles

The transcription factor E2F-1 (E2F) drives cell cycle progression by inducing DNA synthesis. This E2F-dependent pathway is dominant and acts rapidly, even faster than serum stimulation.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Genetics

Background:

  • E2F is a key transcription factor regulating the cell cycle.
  • E2F activity is controlled by interactions with retinoblastoma susceptibility gene product (RB1) and related proteins (p107, p130).
  • Mutational analysis of adenovirus E1A and RB1 suggested a role for E2F in cell cycle progression.

Purpose of the Study:

  • To investigate the role of E2F in cell cycle progression.
  • To determine if the E2F pathway is dominant in cellular proliferation.
  • To compare the kinetics of E2F-1, E1A, and serum in inducing S-phase entry.

Main Methods:

  • Microinjection of GST-E2F-1 fusion protein into quiescent Balb/c 3T3 cells.
  • Co-injection experiments using GST-E2F-1 and a dominant inhibitory E2F DNA-binding domain protein (GST-E2F(95-191)).

Related Experiment Videos

  • Co-injection of dominant inhibitory E2F protein with 12S E1A protein.
  • Analysis of the time interval for quiescent cells to enter S-phase post-microinjection.

    • Main Results:

    • Microinjected GST-E2F-1 induced DNA synthesis in quiescent cells.
    • Co-injection of GST-E2F-1 and GST-E2F(95-191) blocked S-phase induction.
    • Co-injection of dominant inhibitory E2F with 12S E1A blocked E1A-mediated DNA synthesis, indicating E2F pathway dominance.
    • E2F-1 induced S-phase entry more rapidly than E1A or serum.

    Conclusions:

    • E2F-1 is a potent inducer of DNA synthesis and cell cycle progression.
    • The E2F-dependent pathway plays a dominant role in mediating proliferation signals.
    • E2F-1 acts as a rapid regulator of the G1/S transition.